AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30571406
Drug: No endovascular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No endovascular treatment (non-EVT)
Trial: 26685004
Drug: mepolizumab (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mepolizumab (100 mg, n = 9)
Trial: 22647518
Drug: Elinogrel (IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elinogrel (IV 80 or 120 mg followed by oral 50, 100, or 150 mg twice daily)
Trial: 22647518
Drug: Clopidogrel (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (300 or 600 mg pre-procedure followed by 75 mg daily)
Trial: 15916717
Drug: Isradipine (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (0 or 30 mg sustained release each evening prior to testing, plus 0 or 15 mg immediate release each morning 2 hours before cocaine infusion)
Trial: 15916717
Drug: Intravenous cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cocaine (0, 0.325, and 0.650 mg/kg)
Trial: 1976875
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and intravenous heparin
Trial: 27451450
Drug: Bifidobacterium bifidum
RxNorm normalized name: Bifidobacterium Bifidum
DrugBank: Bifidobacterium bifidum (DB16538)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bifidobacterium bifidum strain Bb (approximately one billion live cells daily for 4 weeks)
Trial: 20823393
Drug: Adjunctive cilostazol
RxNorm normalized name: Cilostazol
DrugBank: Cilostazol (DB01166)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjunctive cilostazol 100 mg twice daily (triple group; n=69)
Trial: 20823393
Drug: High maintenance-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High maintenance-dose clopidogrel 150 mg daily (high-MD group; n=65)
Trial: 10021951
Drug: Spinal anaesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anaesthesia with 100 mg lidocaine 5% with 7.5% dextrose
Trial: 10021951
Drug: Epidural anaesthesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural anaesthesia with 600 mg lidocaine 2%
Trial: 7850821
Drug: Cilazapril (CLZ)
RxNorm normalized name: cilazapril
DrugBank: Cilazapril (DB01340)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilazapril (CLZ) 5 mg plus Hydrochlorothiazide (HCTZ) 12.5 mg
Trial: 7850821
Drug: Cilazapril (CLZ)
RxNorm normalized name: cilazapril
DrugBank: Cilazapril (DB01340)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilazapril (CLZ) monotherapy
Trial: 7850821
Drug: Hydrochlorothiazide (HCTZ)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ) 12.5 mg or 25 mg
Trial: 2903182
Drug: Diazepam (≤30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (≤30 mg/day)
Trial: 28232118
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg terbutaline via Turbuhaler® M2
Trial: 28232118
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg terbutaline via Turbuhaler® M2
Trial: 28232118
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg terbutaline via Turbuhaler® M3
Trial: 28232118
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg terbutaline via Turbuhaler® M3
Trial: 21492750
Drug: CMT (Chiropractic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMT (Chiropractic Manipulative Therapy)
Trial: 21492750
Drug: CMT +
RxNorm normalized name: Carvedilol
DrugBank: Carvedilol (DB01136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CMT + LLLT (Combination Therapy)
Trial: 19059939
Drug: All-trans retinoic
RxNorm normalized name: all trans Retinoic acid
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All-trans retinoic acid (as an adjunct to intensive chemotherapy)
Trial: 12792354
Drug: Treatment-naive patients
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-naive patients
Trial: 17043836
Drug: Treatment-experienced patients
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-experienced patients
Trial: 17043836
Drug: Nucleoside reverse
RxNorm normalized name: Non-nucleoside reverse transcriptase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nucleoside reverse transcriptase inhibitors resistance
Trial: 17043836
Drug: Non-nucleoside reverse
RxNorm normalized name: Non-nucleoside reverse transcriptase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-nucleoside reverse transcriptase inhibitors resistance
Trial: 17043836
Drug: Protease inhibitors
RxNorm normalized name: Protease inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protease inhibitors resistance
Trial: 12510813
Drug: IV neridronate
RxNorm normalized name: etidronate
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV neridronate (100 mg infused intravenously for 30 minutes every 3 months)
Trial: 2662738
Drug: Heparin (5,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (5,000 IU in bolus injection)
Trial: 31991203
Drug: Kai-Xin-San (KXS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kai-Xin-San (KXS) treatment in DPs
Trial: 31991203
Drug: Kai-Xin-San (KXS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kai-Xin-San (KXS) treatment in CUMS rats
Trial: 22457321
Drug: Degarelix 240
RxNorm normalized name: Degarelix
DrugBank: Degarelix (DB06699)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Degarelix 240 mg initial dose followed by 80 mg monthly maintenance
Trial: 22457321
Drug: Degarelix 240
RxNorm normalized name: Degarelix
DrugBank: Degarelix (DB06699)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Degarelix 240 mg initial dose followed by 160 mg monthly maintenance
Trial: 16126052
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 50 mcg twice daily
Trial: 16126052
Drug: Montelukast (MON)
DrugBank: Montelukast (DB00471)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Montelukast (MON) 5 mg once daily
Trial: 10068868
Drug: C-type natriuretic
RxNorm normalized name: C-type natriuretic peptide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C-type natriuretic peptide (CNP) at pathophysiological plasma levels, intravenous infusion of synthetic human CNP-22 (2 pmol kg-1 min for 2 h)
Trial: 31232712
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate therapy for 6 weeks
Trial: 31232712
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate therapy for 6 months
Trial: 24107876
Drug: Lacosamide (100-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacosamide (100-400 mg per day)
Trial: 22036019
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg aspirin (per-protocol analysis for 258 participants)
Trial: 22036019
Drug: Aspirin placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin placebo (per-protocol analysis for 250 participants)
Trial: 22036019
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg aspirin (per-protocol analysis)
Trial: 22036019
Drug: Aspirin placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin placebo (per-protocol analysis)
Trial: 15669214
Drug: Serotonin noradrenaline
RxNorm normalized name: serotonin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serotonin noradrenaline reuptake inhibitors (SNRIs)
Trial: 8401618
Drug: Pefloxacin 800
RxNorm normalized name: pefloxacin
DrugBank: Pefloxacin (DB00487)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pefloxacin 800 mg at the time of anaesthetic induction
Trial: 30043582
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine in addition to conventional Western medicine
Trial: 27228511
Drug: Epidural Steroid
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural Steroid Injections (ESIs)
Trial: 24970708
Drug: Internet-based guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based guided self-help treatment (ICBT)
Trial: 23427388
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicine (TCM) plus anti-infection and conventional medicine treatment
Trial: 23427388
Drug: Anti-infection plus
RxNorm normalized name: gentian violet
DrugBank: Gentian violet cation (DB00406)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anti-infection plus conventional medicine treatment
Trial: 18720692
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide (TAC) (20 mg)
Trial: 8666599
Drug: Pneumatic plantar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumatic plantar compression and aspirin
Trial: 6224469
Drug: Thiabendazole (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiabendazole (50 mg kg‐1 daily for two days)
Trial: 6224469
Drug: Thiabendazole (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiabendazole (100 mg kg‐1 daily for two days)
Trial: 6224469
Drug: Metronidazole (30-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (30-40 mg kg‐1 t.d.s. for three days)
Trial: 21999719
Drug: Community care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community care (CC) participants received smoking-cessation pamphlets and information on local treatment programs
Trial: 19843797
Drug: Intrathecal hyperbaric
RxNorm normalized name: beractant
DrugBank: Beractant (DB06761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecal hyperbaric bupivacaine 7 mg
Trial: 19843797
Drug: Intrathecal hyperbaric
RxNorm normalized name: beractant
DrugBank: Beractant (DB06761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecal hyperbaric bupivacaine 8 mg
Trial: 17204951
Drug: Omeprazole (0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (0.7 mg/kg/d)
Trial: 11228177
Drug: Intravenous doxercalciferol
RxNorm normalized name: Doxercalciferol
DrugBank: Doxercalciferol (DB06410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous doxercalciferol (1alphaD(2))
Trial: 11228177
Drug: Oral doxercalciferol
RxNorm normalized name: Doxercalciferol
DrugBank: Doxercalciferol (DB06410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral doxercalciferol (1alphaD(2))
Trial: 9442826
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline nasal spray (placebo)
Trial: 7931476
Drug: Observation subsequent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Observation subsequent to local treatment
Trial: 3495653
Drug: Formula containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formula containing 1.8 g protein/100 kcal with whey/casein ratios 18:82, 34:66, or 50:50
Trial: 27107209
Drug: 8IU low
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 8IU low dose intranasal oxytocin
Trial: 20496733
Drug: Sulfasalazine (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfasalazine (oral administration)
Trial: 18005471
Drug: Remifentanil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil infusion (0.25 microg kg(‐1) min(‐1))
Trial: 18005471
Drug: Fentanyl (total
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (total dose 2.6 +/- 0.3 mg)
Trial: 15956292
Drug: Vitamin D2-fortified
RxNorm normalized name: vitamin D2
DrugBank: Ergocalciferol (DB00153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin D2-fortified cheese (5880 IU/56.7-g serving)
Trial: 15956292
Drug: Water (32,750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water (32,750 IU/250 mL)
Trial: 12109926
Drug: Antipsychotics (specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotics (specific agents not detailed)
Trial: 12109926
Drug: QTc-prolonging drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: QTc-prolonging drugs
Trial: 12109926
Drug: Antipsychotics with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotics with marked QTc prolongation
Trial: 7732330
Drug: Cisapride (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (20 mg twice daily) + Ranitidine (150 mg twice daily)
Trial: 8174947
Drug: Cisapride (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (20 mg twice daily)
Trial: 2258379
Drug: Amitriptyline (50-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (50-150 mg/day)
Trial: 6991103
Drug: Chemoimmunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoimmunotherapy with moderate doses of methotrexate and L-asparaginase added to standard doses of 5-fluorouracil, Adriamycin, and cyclophosphamide, along with Corynebacterium parvum or Pseudomonas vaccine.
Trial: 28403798
Drug: Cobicistat-boosted darunavir
RxNorm normalized name: cobicistat / darunavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cobicistat-boosted darunavir (800 mg) with 2 N(t)RTIs, once daily for 48 weeks
Trial: 23669567
Drug: Intravesical oxybutynin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical oxybutynin 10 mg
Trial: 23669567
Drug: Oral oxybutynin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral oxybutynin 5 mg
Trial: 23669567
Drug: Intravesical oxybutynin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical oxybutynin (7 doses of 10 mg)
Trial: 19235072
Drug: Social-cognitive theories
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social-cognitive theories (e.g. Transtheoretical model, Theory of Planned Behaviour, Protection Motivation Theory, Social Cognitive Theory)
Trial: 8944120
Drug: Iopamidol 370
RxNorm normalized name: iopamidol 370 mg iodine/mL (76 %) INTRAVEN KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopamidol 370 mg l/l
Trial: 8944120
Drug: Ioxaglate 350
RxNorm normalized name: ioxaglate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ioxaglate 350 mg l/l
Trial: 8944120
Drug: Iopamidol 300
RxNorm normalized name: iopamidol 300 mg iodine/mL (61 %) INTRAVEN KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopamidol 300 mg l/l
Trial: 8944120
Drug: Ioxaglate 320
RxNorm normalized name: ioxaglate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ioxaglate 320 mg l/l
Trial: 1720488
Drug: Isradipine at
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine at 1.25‐2.5 mg twice daily
Trial: 6749440
Drug: Sulconazole nitrate
RxNorm normalized name: Sulconazole Nitrate
DrugBank: Sulconazole (DB06820)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulconazole nitrate 1.0 percent cream
Trial: 6749440
Drug: Miconazole nitrate
RxNorm normalized name: Miconazole Nitrate
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Miconazole nitrate 2.0 percent cream
Trial: 31850996
Drug: Standard intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard intravenous fluid regimen (S-group)
Trial: 31850996
Drug: Restrictive intravenous
RxNorm normalized name: Pinus spp. wood destructive distillate
DrugBank: Pine tar (DB15840)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Restrictive intravenous fluid regimen (R-group)
Trial: 31141394
Drug: Sports drink
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sports drink (Gatorade®); 805 ml fluid intake, 6.5 MJ energy intake, 187 g carbohydrate intake; p=0.002 for energy, p<0.001 for carbohydrate
Trial: 31141394
Drug: Water; 751
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water; 751 ml fluid intake, 5.7 MJ energy intake, 151 g carbohydrate intake
Trial: 31141394
Drug: Sports drink
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sports drink (Gatorade®); 1,047 ml acute fluid intake, 3,337 ml total fluid intake at end of trial days; p=0.004 for acute fluid intake, p<0.01 for total fluid intake
Trial: 31141394
Drug: Low-alcohol beer
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-alcohol beer (Hahn Ultra®); 850 ml acute fluid intake, 2,982 ml total fluid intake at end of trial days
Trial: 25867599
Drug: Enzyme-Modified Ginseng
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enzyme-Modified Ginseng Extract (EG) cream
Trial: 19126049
Drug: Isotretinoin treatment
RxNorm normalized name: Isotretinoin
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isotretinoin treatment group
Trial: 19126049
Drug: Topical treatment
RxNorm normalized name: Hongo Killer Treatment Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical treatment group
Trial: 16389910
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment allocation
Trial: 12407487
Drug: Alcohol-based melaleuca
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol-based melaleuca oral solution, administered four times daily for 2-4 weeks
Trial: 12407487
Drug: Alcohol-free melaleuca
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol-free melaleuca oral solution, administered four times daily for 2-4 weeks
Trial: 8748337
Drug: Topical anesthetic
RxNorm normalized name: Topical anesthetic
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical anesthetic cream, EMLA
Trial: 8748337
Drug: Placebo ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ointment (Vaseline)
Trial: 20662863
Drug: Immediate implants
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate implants placed in fresh extraction sockets
Trial: 20595193
Drug: Acetyl-L-carnitine (ALC)
RxNorm normalized name: acetyl-L-carnitine
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-L-carnitine (ALC) 3 g/day
Trial: 20595193
Drug: Acetyl-L-carnitine (ALC)
RxNorm normalized name: acetyl-L-carnitine
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-L-carnitine (ALC) 1 g/day
Trial: 17174460
Drug: Crocus sativus
RxNorm normalized name: CROCUS SATIVUS WHOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crocus sativus petal 15 mg bid (morning and evening)
Trial: 17174460
Drug: Fluoxetine 10
RxNorm normalized name: fluoxetine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 10 mg bid (morning and evening)
Trial: 12473257
Drug: Perhexiline treatment
RxNorm normalized name: perhexiline
DrugBank: Perhexiline (DB01074)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perhexiline treatment for 3 days
Trial: 12473257
Drug: Perhexiline treatment
RxNorm normalized name: perhexiline
DrugBank: Perhexiline (DB01074)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perhexiline treatment
Trial: 7699528
Drug: Prednisone 1
RxNorm normalized name: prednisone 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 1 mg/kg
Trial: 7699528
Drug: Prednisone 2
RxNorm normalized name: prednisone 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 2 mg/kg
Trial: 18306372
Drug: Nontaxane-based therapies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nontaxane-based therapies
Trial: 10506041
Drug: Single intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single intravenous 2.2 g dose of co-amoxiclav
Trial: 8671156
Drug: Triptorelin (gonadotrophin-releasing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triptorelin (gonadotrophin-releasing hormone agonist)
Trial: 2006616
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Atenolol + Nifedipine)
Trial: 6751338
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 80 micrograms atropine methonitrate and 450 micrograms reproterol
Trial: 31796028
Drug: Oral Health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Health Care Package (OHCP) delivered to mothers of 1-6-year-old children
Trial: 30033159
Drug: 0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg/kg caffeine (placebo)
Trial: 30033159
Drug: Caffeine treatment
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine treatment overall
Trial: 30033159
Drug: Caffeine treatment
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine treatment and BMI
Trial: 27236320
Drug: Voriconazole 50
RxNorm normalized name: voriconazole 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voriconazole 50 mg oral
Trial: 27236320
Drug: Voriconazole 400
RxNorm normalized name: Voriconazole
DrugBank: Voriconazole (DB00582)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Voriconazole 400 mg oral